Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02781220 · ClinicalTrials.gov registry record
Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial
A clinical trial, sponsored by University of Utah.
- Terminated
- Registry status
- 69
- Enrollment target
NCT02781220: Clinical Trial study, sponsored by University of Utah.
NCT02781220 is a clinical trial that was terminated before completion, run by University of Utah. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02781220 was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- 69 participants
- Enrollment target
Study Summary
The main purpose of this study is to build upon the evidence captured in the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS; NCT02420756) trial to include valuable information regarding patient-reported outcomes and physician confidence in diagnosis and management based on the Implications for Management of PET Amyloid Classification Technology (IMPACT; NCT number not yet assigned) trial design.
Primary Outcome
% of 13 care practices that differ before and after the amyloid PET scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2016-07 |
| Est. Completion | 2023-06-10 |
Why NCT02781220 stopped before completion
NCT02781220 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 69 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02781220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02781220 about?
NCT02781220 is a clinical study titled "Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial". The main purpose of this study is to build upon the evidence captured in the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS; NCT02420756) trial to include valuable information regarding patient-reported outcomes and physician confidence in diagnosis and management based on the Implications ...
What is the current status of trial NCT02781220?
This trial is currently terminated. The enrollment target is 69 participants. The study started on 2016-07. Estimated completion is 2023-06-10.
Who is sponsoring clinical trial NCT02781220?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia